Literature DB >> 15816431

Successful preoperative treatment for hepatocellular carcinoma with tumor thrombus in the major portal branch by three-dimensional conformal radiation therapy--two case reports.

Hiroshi Wada1, Yo Sasaki, Terumasa Yamada, Hiroaki Ohigashi, Isao Miyashiro, Kohei Murata, Yuichiro Doki, Osamu Ishikawa, Kinji Nishiyama, Shingi Imaoka.   

Abstract

The prognosis of hepatocellular carcinoma (HCC) patients with tumor thrombus in the main portal branch (PVTT) is very poor and a standard treatment regimen for HCC with PVTT has not yet been established. Therefore, a new strategy is necessary to control the patients of HCC with PVTT. Conventional radiation therapy for HCC was not effective because of low liver tolerance. On the other hand, because three-dimensional conformal radiation therapy (3D-CRT) can focus high-dose irradiation on a small area, we tried it for patients with PVTT as the preoperative adjuvant treatment. 3D-CRT which targeted the PVTT was performed for two HCC patients with PVTT before radical hepatectomy. Treatment schedules of 3D-CRT were as follows: in Case 1, the daily fraction size was 3 Gy, given five times per week, and the total dose was 39 Gy. In Case 2, the daily size was 6 Gy and the total dose was 60 Gy. Three or four weeks after 3D-CRT, the main tumor and PVTT were completely removed. On histological examination, the PVTT showed complete necrosis in Case 1, and 60% necrosis in Case 2. No serious complications occurred, and there have been no recurrences for more than one year after surgery in both cases. 3D-CRT targeting the PVTT may be promising as a preoperative adjuvant therapy for HCC with PVTT.

Entities:  

Mesh:

Year:  2005        PMID: 15816431

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  4 in total

1.  Combination of Sorafenib, Camrelizumab, Transcatheter Arterial Chemoembolization, and Stereotactic Body Radiation Therapy as a Novel Downstaging Strategy in Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Case Series Study.

Authors:  Yun Huang; Zeyu Zhang; Weijun Liao; Kuan Hu; Zhiming Wang
Journal:  Front Oncol       Date:  2021-08-02       Impact factor: 6.244

2.  Should transarterial chemoembolization be given before or after intensity-modulated radiotherapy to treat patients with hepatocellular carcinoma with portal vein tumor thrombus? a propensity score matching study.

Authors:  Xiaolong Li; Weixing Guo; Lei Guo; Wan Yee Lau; Naijian Ge; Kang Wang; Shuqun Cheng
Journal:  Oncotarget       Date:  2018-05-11

3.  Preoperative Stereotactic Body Radiotherapy to Portal Vein Tumour Thrombus in Hepatocellular Carcinoma: Clinical and Pathological Analysis.

Authors:  Noriko Kishi; Naoyuki Kanayama; Takero Hirata; Shingo Ohira; Kentaro Wada; Yoshifumi Kawaguchi; Koji Konishi; Shigenori Nagata; Shin-Ichi Nakatsuka; Shigeru Marubashi; Akira Tomokuni; Hiroshi Wada; Shogo Kobayashi; Yasuhiko Tomita; Teruki Teshima
Journal:  Sci Rep       Date:  2020-03-05       Impact factor: 4.379

Review 4.  Neoadjuvant Therapy for Hepatocellular Carcinoma.

Authors:  Zongyi Yin; Dongying Chen; Shuang Liang; Xiaowu Li
Journal:  J Hepatocell Carcinoma       Date:  2022-08-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.